Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
O95502
UPID:
NPTXR_HUMAN
Alternative names:
-
Alternative UPACC:
O95502
Background:
The Neuronal pentraxin receptor plays a crucial role in the nervous system, particularly in synaptic remodeling and the synaptic clustering of AMPA glutamate receptors at certain excitatory synapses. This function is vital for synaptic plasticity, a fundamental mechanism for learning and memory.
Therapeutic significance:
Understanding the role of Neuronal pentraxin receptor could open doors to potential therapeutic strategies. Its involvement in synaptic processes suggests its potential relevance in neurological conditions, offering a promising avenue for research into novel treatments.